Mitochondrial translocator-protein ligand etifoxine reduces pain symptoms and protects against motor dysfunction development following peripheral nerve injury in rats
- DOI
- 10.1016/j.neuropharm.2025.110456
- Published
- 2025-08
- Container
- Neuropharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuropharm.2025.110456,
title = {Mitochondrial translocator-protein ligand etifoxine reduces pain symptoms and protects against motor dysfunction development following peripheral nerve injury in rats},
author = {Yaseen Awad-Igbaria and Reem Sakas and Lama Milhem and Tom Fishboom and Aviv Ben-Menashe and Doron Edelman and Alon Shamir and Jean F. Soustiel and Eilam Palzur},
year = {2025},
journal = {Neuropharmacology},
doi = {10.1016/j.neuropharm.2025.110456},
url = {https://doi.org/10.1016/j.neuropharm.2025.110456}
}RIS
TY - JOUR TI - Mitochondrial translocator-protein ligand etifoxine reduces pain symptoms and protects against motor dysfunction development following peripheral nerve injury in rats AU - Yaseen Awad-Igbaria AU - Reem Sakas AU - Lama Milhem AU - Tom Fishboom AU - Aviv Ben-Menashe AU - Doron Edelman AU - Alon Shamir AU - Jean F. Soustiel AU - Eilam Palzur PY - 2025 JO - Neuropharmacology DO - 10.1016/j.neuropharm.2025.110456 UR - https://doi.org/10.1016/j.neuropharm.2025.110456 ER -
APA
Awad-Igbaria, Y., Sakas, R., Milhem, L., Fishboom, T., Ben-Menashe, A., Edelman, D., Shamir, A., Soustiel, J. F., & Palzur, E. (2025). Mitochondrial translocator-protein ligand etifoxine reduces pain symptoms and protects against motor dysfunction development following peripheral nerve injury in rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2025.110456
Source records
- crossref · retrieved 2026-09-26T16:48:49.369Z